Journal of Current Glaucoma Practice最新文献

{"title":"Enhanced Visibility of the Retinal Nerve Fiber Layer Defects by the Underlying Diffuse Choroidal Angioma in Sturge Weber Syndrome with Glaucoma.","authors":"Ahmed M Abdelrahman","doi":"10.5005/jp-journals-10078-1385","DOIUrl":"10.5005/jp-journals-10078-1385","url":null,"abstract":"<p><strong>Aim: </strong>To describe a unique finding in a patient with Sturge-Weber syndrome (SWS) accompanied by glaucoma.</p><p><strong>Background: </strong>Cases with SWS may have an associated choroidal angioma and glaucoma. The localized retinal nerve fiber layer (RNFL) defects induced by the associated glaucoma are better detected against the red background of the associated choroidal angioma.</p><p><strong>Case description: </strong>A 15-year-old boy was presented with left-side SWS. The case was subjected to full clinical examination, intraocular pressure (IOP) measurements, color fundus photography, ultrasonography, visual field assessment, and optical coherence tomography (OCT) of the peripapillary RNFL and ganglion cell layer (GCC) analysis. The main clinical finding was the enhanced detection of defects of the RNFL against the red color of associated choroidal angioma in this glaucomatous eye.</p><p><strong>Conclusion: </strong>There is enhanced clinical visibility of RNFL defects in presence of associated diffuse choroidal angioma in Sturge-Weber glaucoma.</p><p><strong>Clinical significance: </strong>Easier clinical detection of RNFL defects in SWS glaucoma associated with diffuse choroidal angioma.</p><p><strong>How to cite this article: </strong>Abdelrahman AM. Enhanced Visibility of the Retinal Nerve Fiber Layer Defects by the underlying Diffuse Choroidal Angioma in Sturge Weber Syndrome with Glaucoma. J Curr Glaucoma Pract 2023;17(1):52-54.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"52-54"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/e7/jocgp-17-52.PMC10203333.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals.","authors":"Goktug Firatli,&nbsp;Alperen Elibol,&nbsp;Ekin Altinbas,&nbsp;Cemre Ayhan,&nbsp;Ali Riza Cenk Celebi","doi":"10.5005/jp-journals-10078-1392","DOIUrl":"10.5005/jp-journals-10078-1392","url":null,"abstract":"<p><strong>Aim: </strong>The purpose of this study is to investigate the difference of change in the retinal nerve fiber layer (RNFL) and the ganglion cell complex (GCC) thickness according to age in glaucoma suspect individuals and healthy subjects.</p><p><strong>Materials and methods: </strong>Thicknesses of RNFL and GCC were measured with spectral domain optical coherence tomography (SD-OCT) in glaucoma-suspected individuals and healthy subjects. The differences in age, overall mean, four quadrants, and 12 clock-hour sectors of RNFL and overall mean, superior half, and inferior half GCC thicknesses between glaucoma suspects and healthy participants were analyzed and compared using linear regression analyses.</p><p><strong>Results: </strong>There were 201 glaucoma-suspect individuals and 121 healthy subjects with a mean age of 38.89 and 40.26 years, respectively (<i>p</i> = 0.27). The mean overall RNFL thickness was found to be 97.76 and 97.43 µm in healthy individuals and glaucoma suspects (<i>p</i> = 0.72). The mean overall GCC thickness was found to be 111.30 and 104.67 µm in healthy individuals and glaucoma suspects, respectively (<i>p</i> < 0.001). There was a 0.11 µm decrease per year found in overall GCC thickness in glaucoma suspects and 0.23 µm decreases per year in overall GCC thickness in healthy individuals (<i>p</i> < 0.001). There was a 0.02 µm decrease per year found in overall RNFL thickness in glaucoma suspects and a 0.29 µm decrease per year in overall RNFL thickness in healthy individuals (<i>p</i> < 0.001). However, these per-year decreases in GCC thickness glaucoma suspects and healthy individuals were not found to be statistically significant (<i>p</i> = 0.21); on the other hand, this difference for RNFL thickness was significant (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>It was found that the thicknesses of RNFL and GCC were different between glaucoma suspects and healthy individuals. However, age-related decay in the RNFL and GCC thicknesses was not uniform in healthy individuals and glaucoma suspects.</p><p><strong>Clinical significance: </strong>It was found that the RNFL thickness and GCC thickness were lower in glaucoma suspects than in healthy controls eyes. However, an age-related decrease of RNFL and GCC thicknesses were found to be less in glaucoma suspects compared with healthy controls.</p><p><strong>How to cite this article: </strong>Firatli G, Elibol A, Altinbas E, <i>et al.</i> The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals. J Curr Glaucoma Pract 2023;17(1):22-29.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"22-29"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/57/jocgp-17-22.PMC10203334.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes.","authors":"Rita C Basto,&nbsp;Júlio Almeida,&nbsp;Joana N Roque,&nbsp;Susana P Henriques,&nbsp;Ana S Gonçalves,&nbsp;Fernando T Vaz,&nbsp;Helena Carvalho,&nbsp;Isabel Prieto","doi":"10.5005/jp-journals-10078-1395","DOIUrl":"10.5005/jp-journals-10078-1395","url":null,"abstract":"<p><strong>Aim: </strong>This study evaluates the safety and efficacy of micropulse transscleral cyclophotocoagulation (MPTSCPC) in glaucoma patients, with standard parameters, over a 24-month period.</p><p><strong>Methods: </strong>Retrospective analysis of 61 eyes undergoing MPTSCPC from January 2018 to December 2020 was carried out. Patients received 160 seconds of laser, with settings of 2000 mW/cm² and a duty cycle of 31.3%.</p><p><strong>Results: </strong>A total of 61 eyes were included, arranged in an age distribution of 73.9 ± 10.8 years. The most frequent diagnosis was primary open-angle glaucoma (POAG), with a mean best-corrected visual acuity (BCVA) of 5/10 in the Snellen Visual chart. Around 37.7% of the eyes had undergone at least one glaucoma filtration surgery prior to MPTSCPC. The mean pretreatment intraocular pressure (IOP) was 24.9 ± 8.6 mm Hg. Except for the contrast at 24 months, at every other follow-up visit, there was a significant reduction (<i>p</i> ≤ 0.001) in IOP and in the number of topical drugs required to control IOP, from four (baseline) to three, with oral acetazolamide suspension in most cases. The total success rate (absolute and clinical successes combined) was 81.9% after 1 year of the treatment. There was no drop in visual acuity or cases of serious complications. There is a positive and significant correlation between prior glaucoma surgery and the need for reinterventions (<i>p</i> = 0.028).</p><p><strong>Conclusions: </strong>Micropulse transscleral cyclophotocoagulation (MPTSCPC) is an effective and safe procedure for reducing IOP within a broad spectrum of glaucoma patients. Additional studies are needed to confirm the current indications, widen their scope, and determine the optimal treatment settings on an individual basis.</p><p><strong>How to cite this article: </strong>Basto RC, Almeida J, Roque JN, <i>et al.</i> Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes. J Curr Glaucoma Pract 2023;17(1):30-36.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"30-36"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/50/jocgp-17-30.PMC10203329.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey.","authors":"Kirti Singh,&nbsp;Arshi Singh","doi":"10.5005/jp-journals-10078-1396","DOIUrl":"10.5005/jp-journals-10078-1396","url":null,"abstract":"<p><strong>Aim: </strong>This review summarizes current data on Rho-kinase (ROCK) inhibitors use in ocular diseases, primarily glaucoma.</p><p><strong>Background: </strong>Translational research over the last decade culminating in the development of ROCK inhibitors has provided a much-needed shot in the arm to glaucoma pharmacopeia. ROCK pathway is intricately involved in cytoskeletal modulation with action on cell morphology, cell motility, cell adhesion, cell apoptosis, and smooth muscle contraction. This cytoskeletal modulation property has been utilized to modify trabecular meshwork (TM) resistance, resulting in the discovery of ROCK inhibitors to increase trabecular outflow.</p><p><strong>Review results: </strong>Multicentric trials on ROCK inhibitors for antiglaucoma medications are summarized. The focus is on linking pharmacological action to the clinical utility of these drugs. While the Rho Kinase Elevated intraocular Pressure (IOP) Treatment (ROCKET) trials compared monotherapy with ROCK inhibitor netarsudil vs timolol, MERCURY trials compared a fixed dose combination of latanoprost and ROCK inhibitor netarsudil [fixed combination netarsudil-latanoprost (FCNL)] vs monotherapy with either and bimatoprost-timolol combination. While ROCKET trials showed ROCK inhibitors to be non-inferior to timolol, MERCURY trials showed FCNL achieving a much greater IOP reduction than monotherapy with either. Conjunctival hyperemia was the most common side effect reported with ROCK inhibitor use.</p><p><strong>Conclusion: </strong>Moderate efficacy of ROCK inhibitors with a common side effect of conjunctival hyperemia, makes it an adjunctive antiglaucoma drug of choice and not a first-line therapy.</p><p><strong>Clinical significance: </strong>ROCK inhibitors' action on diseased TM is more physiological compared to available antiglaucoma medications that either reduce aqueous secretion or enhance uveoscleral outflow. The property of ROCK inhibition to stabilize the endothelium of both retinal vasculature and cornea has opened a new chapter in the treatment of diabetic retinopathy and corneal decompensation.</p><p><strong>How to cite this article: </strong>Singh K, Singh A. Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey. J Curr Glaucoma Pract 2023;17(1):44-48.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"44-48"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/76/jocgp-17-44.PMC10203326.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New Gonioscopy Technique for Finding Schwalbe's Line: The Ortiz Maneuver.","authors":"Oscar Albis-Donado,&nbsp;Gabriel E Ortiz-Arismendi,&nbsp;Shibal Bhartiya","doi":"10.5005/jp-journals-10078-1399","DOIUrl":"10.5005/jp-journals-10078-1399","url":null,"abstract":"<p><p>A new technique for performing gonioscopy that facilitates finding Schwalbe´s line, and lowers the amount of time and light that enters through the pupil is presented. The technique is an alternative to the classic corneal wedge technique and is feasible in the horizontal quadrants without further adjustments to the slit lamp, in contrast to the tilting usually needed for these quadrants. Clinical photos and online videos are presented.</p><p><strong>How to cite this article: </strong>Albis-Donado O, Ortiz-Arismendi GE, Bhartiya S. New Gonioscopy Technique for Finding Schwalbe's Line: The Ortiz Maneuver. J Curr Glaucoma Pract 2023;17(1):37-39.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"37-39"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/cf/jocgp-17-37.PMC10203330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9518284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Micropulse Cyclophotocoagulation vs Selective Laser Trabeculoplasty: Effects on Corneal Endothelial Cells and Intraocular Pressure.","authors":"Aylin Garip Kuebler,&nbsp;Siegfried Priglinger,&nbsp;Lukas Reznicek","doi":"10.5005/jp-journals-10078-1393","DOIUrl":"10.5005/jp-journals-10078-1393","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effects of micropulse transscleral cyclophotocoagulation (mCPC) and selective laser trabeculoplasty (SLT) on endothelial cell density (ECD) and reduction of the intraocular pressure (IOP) in patients with primary-open angle glaucoma (POAG).</p><p><strong>Patients and methods: </strong>In this observational, retrospective study, 40 eyes with POAG were included. Patients were divided into three groups-group I was treated with SLT (<i>n</i> = 13), group II was treated with mCPC (<i>n</i> = 13), and group III included age-matched patients with medically treated glaucoma (<i>n</i> = 14) (control group). In both treatment groups (SLT and mCPC) preoperative and postoperative findings of best-corrected visual acuity (BCVA), ECD, and IOP were compared to the control group.</p><p><strong>Results: </strong>The mean time interval before and after the treatment was 215 ± 120 days in group I (SLT) and 273 ± 177 days in group II (mCPC). The follow-up for group III (control group) was 209 ± 103 days. In both treatment groups (SLT and mCPC) there was a statistically significant reduction of the IOP postoperatively (group I: 3.5 ± 3.7 mm Hg (<i>p</i> = 0.005) and group II: 4.3 ± 4.1 mm Hg (<i>p</i> = 0.003)). The mean IOP for group III was 12.9 ± 3.7 mm Hg at visit 1 and did not change significantly (<i>p</i> = 0.353) at visit 2. In all three groups, there was no statistically significant change in ECD at the last visit.</p><p><strong>Conclusion: </strong>According to our results, both SLT and mCPC seem to be effective in lowering the IOP, without showing any statistically significant effect on ECD in patients with POAG.However, larger and longer-term studies are necessary to understand the effects of the SLT and mCPC procedures on ECD.</p><p><strong>How to cite this article: </strong>Garip Kuebler A, Priglinger S, Reznicek L. Micropulse Cyclophotocoagulation vs Selective Laser Trabeculoplasty: Effects on Corneal Endothelial Cells and Intraocular Pressure. J Curr Glaucoma Pract 2023;17(1):40-43.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"40-43"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/f0/jocgp-17-40.PMC10203327.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9518286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of Endotrabeculectomy (Trabecula Ablation Ab Interno with the Forceps) for Open-angle Glaucoma.","authors":"Ihor Y Novytskyy,&nbsp;Markiyan I Novytskyy","doi":"10.5005/jp-journals-10078-1389","DOIUrl":"10.5005/jp-journals-10078-1389","url":null,"abstract":"<p><strong>Aim: </strong>To investigate the efficacy of endotrabeculectomy (ETE) performed either alone or combined with phacoemulsification (phaco) in patients with primary open-angle glaucoma (POAG).</p><p><strong>Materials and methods: </strong>Investigations were done in two groups. The first group (38 patients, 38 eyes) with POAG underwent ETE, and the second group of 126 patients (126 eyes) with POAG and cataracts underwent ETE and phaco. The hypotensive effect of the surgery was evaluated.</p><p><strong>Results: </strong>In the ETE group, the mean intraocular pressure (IOP) was reduced from 20.25 ± 3.30 to 14.94 ± 1.95 mm Hg (26.2% reduction, <i>p</i> < 0.001) at 12 months. The number of medications was reduced from 2.8 ± 1.0 to 1.5 ± 1.0 (<i>p</i> < 0.001) at 12 months after the surgery. In the phaco-ETE group, the mean IOP was reduced from 18.24 ± 3.20 to 14.83 ± 1.71 mm Hg (18.7% reduction, <i>p</i> < 0.001) at 12 months. The mean number of medications was reduced from 2.2 ± 1.1 to 1.0 ± 1.0 (<i>p</i> < 0.001) at 12 months after the surgery. The success rate defined as a final IOP of <16 mm Hg using the Kaplan-Meier curve at 12 months was 73.8%. There were no complications that led to a constant visual decrease.</p><p><strong>Clinical significance: </strong>Our study shows that ETE is technically simple, gives the ability to remove trabecula in any quadrant, and effectively reduces IOP in patients with POAG.</p><p><strong>Conclusion: </strong>Endotrabeculectomy (ETE) is a safe and relatively simple procedure that significantly reduces IOP. The minimally invasive nature of the ETE allows expanding indications for combined treatment of glaucoma and cataract.</p><p><strong>How to cite this article: </strong>Novytskyy IY, Novytskyy MI. Efficacy of Endotrabeculectomy (Trabecula Ablation Ab Interno with the Forceps) for Open-angle Glaucoma. J Curr Glaucoma Pract 2023;17(1):15-21.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"15-21"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/0e/jocgp-17-15.PMC10203332.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Coarsened Exact Matching of Excisional to Plasma-ablative <i>Ab Interno</i> Trabeculectomy.","authors":"Mohamad Dakroub,&nbsp;Raoul Verma-Fuehring,&nbsp;Alicja Strzalkowska,&nbsp;Jost Hillenkamp,&nbsp;Yousef Al Yousef,&nbsp;Nils A Loewen","doi":"10.5005/jp-journals-10078-1384","DOIUrl":"10.5005/jp-journals-10078-1384","url":null,"abstract":"<p><strong>Aim: </strong>To compare ab interno trabeculectomy by trabecular meshwork (TM) excision to plasma-mediated ablation in primary open-angle glaucoma (POAG) patients.</p><p><strong>Methods: </strong>Retrospectively collected data of TrabEx+ (TEx) (<i>n</i> = 56) and Trabectome (T) (<i>n</i> = 99) patients were compared by coarsened exact matching to reduce confounding and matched based on baseline intraocular pressure (IOP) and age. The primary outcomes were IOP and the number of glaucoma medications. Complications and the need for additional glaucoma surgery were assessed. Patients were followed for up to 1 year.</p><p><strong>Results: </strong>A total of 53 TEx could be matched to T. Baseline IOP was 16.5 ± 4.6 mm Hg in both; age was 73.7 ± 8.8 and 71.5 ± 9.9 years in TEx and T, respectively. TEx was taking more medications than T (<i>p</i> < 0.001). IOP was reduced to 14.8 ± 4.3 in TEx and to 13.4 ± 3.4 in T at 6 months, and to 14.9 ± 6.0 (<i>p</i> = 0.13) in TEx and to 14.1 ± 3.8 mm Hg (all <i>p</i> < 0.05) in T at 12 months. Medications were reduced at both 6 and 12 months (<i>p</i> < 0.05). No differences were seen between TEx and T at 6 and 12 months. In TEx, only one serious complication occurred, and two patients required further glaucoma surgery.</p><p><strong>Conclusion: </strong>Although both groups had a baseline IOP considered low for ab interno trabeculectomy, IOP and medications were reduced further at 6 and 12 months. IOP reduction did not reach significance in TEx at 12 months. The intergroup comparison did not reveal any significant differences. Both had a low complication rate.</p><p><strong>Clinical significance: </strong>This study investigated subtle differences between a plasma-ablative device, the T, and an excisional device, the TEx, by applying coarsened exact matching. IOP and medications were reduced in both groups at 6 and 12 months, although IOP reduction did not reach significance in TEx at 12 months. The intergroup comparison did not reveal any significant differences, with both devices having a low complication rate.</p><p><strong>How to cite this article: </strong>Dakroub M, Verma-Fuehring R, Strzalkowska A, <i>et al.</i> Coarsened Exact Matching of Excisional to Plasma-ablative <i>Ab Interno</i> Trabeculectomy. J Curr Glaucoma Pract 2023;17(1):9-14.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"9-14"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/1e/jocgp-17-9.PMC10203335.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Large Hyphema following Femtosecond Laser-assisted Cataract Surgery (FLACS) and Trabectome Resulting in Endocapsular Hematoma.","authors":"Eileen L Chang,&nbsp;Nicholas Apostolopoulos,&nbsp;Tahreem A Mir,&nbsp;Isaac G Freedman,&nbsp;Christopher C Teng","doi":"10.5005/jp-journals-10078-1372","DOIUrl":"10.5005/jp-journals-10078-1372","url":null,"abstract":"<p><strong>Aim: </strong>To report a large hyphema following femtosecond laser-assisted cataract surgery (FLACS) and trabectome resulting in endocapsular hematoma.</p><p><strong>Background: </strong>Hyphema has previously been described following trabectome, however, no cases have been reported following FLACS or FLACS combined with microinvasive glaucoma surgery (MIGS). We report a case of a large hyphema following FLACS combined with MIGS that resulted in an endocapsular hematoma.</p><p><strong>Case description: </strong>A 63-year-old myopic female with exfoliation glaucoma underwent FLACS with a trifocal intraocular lens implant and Trabectome in the right eye. Significant intraoperative bleeding ensued following the trabectome and was treated with viscoelastic tamponade, anterior chamber (AC) washout, and cautery. The patient developed a large hyphema with intraocular pressure (IOP) rise that was treated with multiple AC taps, paracentesis, and eye drops. The hyphema took approximately 1 month to completely clear, leaving an endocapsular hematoma. This was treated successfully with Neodymium:Yttrium-Aluminum-Garnet (Nd:YAG) laser posterior capsulotomy.</p><p><strong>Conclusion: </strong>Hyphema may occur with angle-based MIGS in combination with FLACS and may cause endocapsular hematoma. An increase in episcleral venous pressure during the docking and suction phase of the laser may predispose to bleeding. Endocapsular hematoma is an uncommon finding after cataract surgery and may be treated with Nd:YAG posterior capsulotomy.</p><p><strong>How to cite this article: </strong>Chang EL, Apostolopoulos N, Mir TA, <i>et al.</i> Large Hyphema following Femtosecond Laser-assisted Cataract Surgery (FLACS) and Trabectome Resulting in Endocapsular Hematoma. J Curr Glaucoma Pract 2022;16(3):195-198.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"16 3","pages":"195-198"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/a6/jocgp-16-195.PMC9905881.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10738796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ocular and Systemic Factors Associated with Glaucoma.","authors":"Tanuj Dada,&nbsp;Saurabh Verma,&nbsp;Meghal Gagrani,&nbsp;Shibal Bhartiya,&nbsp;Nidhi Chauhan,&nbsp;Kanchan Satpute,&nbsp;Namrata Sharma","doi":"10.5005/jp-journals-10078-1383","DOIUrl":"10.5005/jp-journals-10078-1383","url":null,"abstract":"<p><p>Glaucoma is one of the leading causes of irreversible blindness in the world. Although numerous factors have been implicated in the pathogenesis of glaucoma, the main focus of management still remains lowering the intraocular pressure (IOP) by medical or surgical therapy. However, a major challenge is that many glaucoma patients continue to progress despite good control of IOP. In this regard, the importance of other coexisting factors that may contribute to disease progression needs to be explored. Ophthalmologists need to be aware of ocular risk factors and the impact of systemic diseases and their medications, along with lifestyle modifications on the course of glaucomatous optic neuropathy and adopt a holistic approach in treating the eye as well as the patient to alleviate the suffering from glaucoma in a comprehensive manner.</p><p><strong>How to cite this article: </strong>Dada T, Verma S, Gagrani M, <i>et al.</i> Ocular and Systemic Factors associated with Glaucoma. J Curr Glaucoma Pract 2022;16(3):179-191.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"16 3","pages":"179-191"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/f7/jocgp-16-179.PMC9905876.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10738799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}